InvestorsObserver
×
News Home

Will Akebia Therapeutics Inc (AKBA) Stay at the Top of the Healthcare Sector?

Tuesday, September 26, 2023 01:40 PM | InvestorsObserver Analysts

Mentioned in this article

Will Akebia Therapeutics Inc (AKBA) Stay at the Top of the Healthcare Sector?

Akebia Therapeutics Inc (AKBA) is near the top in its sector according to InvestorsObserver. AKBA gets an overall rating of 62. That means it scores higher than 62% of stocks. Akebia Therapeutics Inc gets a 97 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 62
AKBA has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on AKBA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Akebia Therapeutics Inc Stock Today?

Akebia Therapeutics Inc (AKBA) stock is up 9.73% while the S&P 500 is lower by -1.2% as of 1:31 PM on Tuesday, Sep 26. AKBA is up $0.11 from the previous closing price of $1.13 on volume of 835,867 shares. Over the past year the S&P 500 has gained 17.24% while AKBA is up 300.00%. AKBA lost -$0.54 per share the over the last 12 months. Click Here to get the full Stock Report for Akebia Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App